Foxx Development Holdings Inc. (NASDAQ:FOXX) Short Interest Update

Foxx Development Holdings Inc. (NASDAQ:FOXX – Get Free Report) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 79,645 shares, a growth of 1,495.1% from the May 31st total of 4,993 shares. Currently, 1.7% of the company’s shares are short sold. Based on an average trading volume of 8,717,742 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Foxx Development from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, June 18th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Get Foxx Development alerts:

Get Our Latest Stock Analysis on Foxx Development

Foxx Development Price Performance

NASDAQ:FOXX traded up $0.02 during mid-day trading on Friday, reaching $3.04. 6,191 shares of the company’s stock traded hands, compared to its average volume of 858,938. The company has a 50 day moving average price of $4.19 and a 200-day moving average price of $4.48. The firm has a market capitalization of $21.41 million, a price-to-earnings ratio of -0.44 and a beta of -0.31. Foxx Development has a 12-month low of $1.71 and a 12-month high of $8.88.

Foxx Development (NASDAQ:FOXX – Get Free Report) last released its quarterly earnings data on Wednesday, May 20th. The company reported ($5.19) earnings per share for the quarter. The business had revenue of $8.67 million during the quarter.

Institutional Trading of Foxx Development

An institutional investor recently bought a new position in Foxx Development stock. Citadel Advisors LLC acquired a new position in Foxx Development Holdings Inc. (NASDAQ:FOXX – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,025 shares of the company’s stock, valued at approximately $57,000. Citadel Advisors LLC owned approximately 0.18% of Foxx Development at the end of the most recent quarter. Institutional investors and hedge funds own 60.44% of the company’s stock.

Foxx Development Company Profile

(Get Free Report)

Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company’s core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.

Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.

Featured Articles

• Five stocks we like better than Foxx Development
• Data Center Delays Create Opportunity in These 3 Stocks
• Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally Here
• Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout
• 3 Stocks Building the Future of Agentic AI Payments

Receive News & Ratings for Foxx Development Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foxx Development and related companies with MarketBeat.com's FREE daily email newsletter.